Oxygen Delivery System

NASA’s Exploration Medical Capability (ExMC) is charged to reduce the risk of adverse health and mission outcomes due to limitations of in-flight medical capabilities. They have identified a number of technology gaps, one of which is:
Current spaceflight oxygen delivery systems deliver pure oxygen to the crewmember from high pressure oxygen tanks, which results in a gradual increase in cabin oxygen levels and a localized area of increased oxygen concentration in the vicinity of the crewmember, posing an increased fire hazard.
The Oxygen Concentrator Module (OCM) project is tasked with developing an oxygen delivery system with variable oxygen capability that minimizes localized oxygen build-up and meets the commercial crew vehicle evacuation requirements.
Work focuses on the development of a supplemental oxygen delivery system for crewmembers that pulls oxygen out of the ambient environment instead of using compressed oxygen. This provides better resource optimization and reduces fire hazard by preventing the formation of localized pockets of increased oxygen concentration within the vehicle. The system will provide oxygen support in a closed cabin environment where the atmosphere may be at a reduced pressure and elevated oxygen percentage (compared to terrestrial standard atmosphere composition and pressure).
Future space missions will take astronauts beyond Earth’s orbit. These exploration missions may be long in duration (e.g., 36 months) and will have limited resources. It is vital that each piece of equipment serve as many functions as possible, with built in redundancy. A modular oxygen concentrator that uses the ambient cabin air can serve a number of functions (medical emergency, pre-breathing, atmospheric contamination, or leak) without taxing other spacecraft systems to compensate for an increase in ambient oxygen. This improves mission safety by not exacerbating fire risk, and minimizing system interdependencies.
This gap aligns well with the International Space Station (ISS) Health Maintenance System (HMS) because HMS currently has no oxygen delivery system that can meet commercial crew vehicle evacuation requirements. Concentrating oxygen from cabin air eliminates the up mass associated with oxygen tanks and reduces fire hazard, as it prevents the formation of localized pockets of increased oxygen levels within the vehicle.
An oxygen concentrator for crew medical support is considered vital to provide an ill crewmember with ventilation with oxygen. Providing a method of oxygen therapy that uses cabin air keeps the oxygen levels stable and avoids Environmental Control and Life Support System (ECLSS) intervention required to maintain the cabin oxygen levels.
The medical conditions requiring oxygen supplementation include: Altitude sickness, Anaphylaxis, Burns, Choking/obstructed airway, Cough –URI, bronchitis, pneumonia, inhalation, De Novo cardiac arrhythmia, Decompression sickness, Headache (CO2, SAS, other), Infection – sepsis, Medication overdose/misuse, Neck injury, Radiation sickness, Seizure, Smoke inhalation, and Toxic exposure.
The final flight system for an oxygen delivery system needs to be Food & Drug Administration (FDA) clearable device and should be designed to minimize mass, volume, and power. A demonstration unit for the International Space Station (ISS) should verify the technology and provide oxygen capability for ISS.
There are two US oxygen delivery systems currently used onboard the ISS--the Respiratory Support Pack (RSP) and the Portable Breathing Apparatus (PBA). The RSP uses the ISS 120 psi oxygen lines and delivers pure oxygen up to 12 L/min. The RSP is for medical O2 usage. The PBA consists of a non-refillable portable oxygen bottle that provides 15 minutes of oxygen and also includes a 30 foot hose to attach to the ISS oxygen lines for long term oxygen supply. The P